Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutations

NCT05293626 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Leber Hereditary Optic Neuropathy (LHON)

Interventions

DRUG: NR082 Injection
DEVICE: Injection needle

Sponsor

Neurophth Therapeutics Inc